Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Headlines

Roche sees continued impact of biosimilars, but testing division performance strong

Roche witnessed a slight decrease in Q1 2021 pharmaceutical sales – a drop of 9% compared to the first three months of 2020 - as it faced continued biosimilars competition; the COVID-19 pandemic also played a role.

Looking ahead: Israel sets up 2022 COVID-19 vaccine supply with Pfizer and Moderna

Israel has set up COVID-19 vaccine orders with Pfizer and Moderna this week: marking deals over the longer term for the two companies.

Content provided by PharmaNutra Spa

Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional supplement

An investigation was recently conducted in Italy on around 200 post-Covid patients suffering from persistent fatigue, who were advised to take Apportal for 28 days

Bristol Myers Squibb to build new cell therapy manufacturing site in the Netherlands

Bristol Myers Squibb (BMS) will build a new cell therapy manufacturing site in Leiden, the Netherlands: marking the company’s first cell therapy manufacturing facility in Europe and its fifth globally.

Roche and University of Leeds jointly developed AI test looks to identify best treatment options for bowel cancer patients

A test which uses artificial intelligence (AI) to measure proteins present in some patients with advanced bowel cancer could hold the key to more targeted treatment, according to a study published in Clinical Cancer Research.

Membranes unlock potential to increase cell-free vaccine production

Synthetic biologists based at Northwestern University in the US have discovered a new way to increase production yields of protein-based vaccines five-fold, significantly broadening access to potentially lifesaving medicines.